ANG021

N/A

Report date: 2023/04/24 10:45:58

Base Information

Drug NameANG021
Drug Alias NameANG021ANG-021
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionEnzyme replacements
TargetsNot applicable
Therapy Area/IndicationsMalabsorption Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnagram Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAnagram Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMalabsorption Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A